Cargando…
Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer
Pancreatic cancer has an exclusive inhibitory tumor microenvironment characterized by a dense mechanical barrier, profound infiltration of immunosuppressive cells, and a lack of penetration of effector T cells, which constitute an important cause for recurrence and metastasis, resistance to chemothe...
Autores principales: | Zhang, Huiru, Ye, Longyun, Yu, Xianjun, Jin, Kaizhou, Wu, Weiding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548645/ https://www.ncbi.nlm.nih.gov/pubmed/36225934 http://dx.doi.org/10.3389/fimmu.2022.956984 |
Ejemplares similares
-
Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer: The function of lipid metabolism reprogramming in pancreatic cancer
por: Guo, Duancheng, et al.
Publicado: (2023) -
Innate Lymphoid Cells: Emerging Players in Pancreatic Disease
por: Shi, Saimeng, et al.
Publicado: (2022) -
Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer
por: Shi, Saimeng, et al.
Publicado: (2023) -
TGF-β1-induced RAP2 regulates invasion in pancreatic cancer: RAP2 regulates invasion in pancreatic cancer
por: Jin, Kaizhou, et al.
Publicado: (2022) -
Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer
por: Ye, Longyun, et al.
Publicado: (2022)